Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Am J Surg Pathol. 2014 May;38(5):627–637. doi: 10.1097/PAS.0000000000000163

Table 1.

Clinical characteristics of 9 genetically confirmed HLRCC patients with renal tumors

Pt Sex Age Symptoms Leiomyoma Family Hx at Presentation Kidney Mass Size (cm) pT Metastasis Follow-Up (Month)
1 F 37 Flank pain Uterine at 32 None L /solitary 4.9 pT3a RPLNs DOD (44)
2 M 38 Flank pain, hematuria None None R/solitary 12.5 pT3a RPLNs, adrenal, liver, lung, bone DOD (28)
3 F 32 Abdominal discomfort Uterine (imaging only) N/A (adopted) R/ solitary 9.2 pT3a RPLNs, lung, liver DOD (23)
4 M 24 Flank pain None Mother ovarian ca L /solitary 5 pT3a RPLNs, lung AWD (10)
5 M 61 Flank pain, hematuria None Father RCC, mother breast ca, daughter fibroid L /two masses 15; 3 pT3a RPLNs, adrenal, liver DOD (8)
6 M 42 Flank pain, hematuria None None L /solitary 6.5 pT3a RPLNs, adrenal, liver DOD (8)
7 M 34 Incidental renal mass None Father non-small cell lung ca L /solitary 12.2 pT3a RPLNs AWD (10)
8 F 30 Flank pain None None R /solitary 6.7 pT3a RPLNs, adrenal AWD (12)
9 F 25 Flank pain Yes (but not identified initially) Mother RCC R/solitary 11.5 pT3a RPLNs NED (6)

RPLNs: retroperitoneal lymph nodes; DOD: death of disease; AWD: alive with disease; RCC: renal cell carcinoma; ca:cancer